Apollo Endosurgery Profit Margin 2006-2020 | APEN
Current and historical gross margin, operating margin and net profit margin for Apollo Endosurgery (APEN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Apollo Endosurgery net profit margin as of June 30, 2020 is -81.7%.
|Apollo Endosurgery Annual Profit Margins
|Apollo Endosurgery Quarterly Profit Margins
||Medical Instruments Manufacturing
Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.